Physician profile
John E Kaminski
NPI 1003811605
$2,191.19
in general payments reported to CMS, 2019-2025
9 companies · $611 in 2025
The $611 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $169 · 2021: $197 · 2022: $270 · 2023: $195 · 2024: $337 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $775.39 | 2020-2025 | Hydrus Microstent, Precision7, Tryptyr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $439.32 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $429.17 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $260.73 | 2022-2025 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $102.46 | 2020-2025 | Clariti Contact Lens, Myday Contact Lens |
| Abbvie INC. | $65.01 | 2022 | |
| Allergan, INC. | $56.71 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $46.27 | 2021 | |
| Biotissue Holdings INC. | $16.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kaminski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.